Summary of findings 5. Ectopic pregnancy.
Patient or population: women with threatened miscarriage or a history of recurrent miscarriage Interventions: multiple progestogens (vaginal micronized progesterone, oral micronized progesterone, dydrogesterone and 17‐α‐hydroxyprogesterone) Comparison: placebo and dydrogesterone Outcome: ectopic pregnancy Settings: hospitals | |||||||
Treatment | Direct evidence | Indirect evidence | Anticipated absolute effects for direct estimate | ||||
RR (95% CI) | Certainty | RR (95% CI) | Certainty | Risk with intervention | Risk with comparator | Risk difference with intervention | |
Threatened miscarriage | |||||||
Vaginal micronized progesterone | 0.20 [0.01, 4.14] | ⊕⊕⊝⊝ LOWa | Unavailable | ‐ | 0 per 1000 (vaginal micronized progesterone) | 1 per 1000 (placebo) |
1 fewer per 1000 (from 1 fewer to 3 more) |
Dydrogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
17‐α‐hydroxyprogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
Oral micronized progesteroneversus dydrogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
Recurrent miscarriage | |||||||
Vaginal micronized progesterone | 0.92 [0.31, 2.72] | ⊕⊕⊝⊝ LOWa | Unavailable | ‐ | 15 per 1000 (vaginal micronized progesterone) | 16 per 1000 (placebo) |
2 fewer per 1000 (from 4 fewer to 23 more) |
Dydrogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
17‐α‐hydroxyprogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
Oral micronized progesteroneversus dydrogesterone | Unavailable | ‐ | Unavailable | ‐ | See comment* | See comment** | See comment*** |
*No included studies or there are no events in included studies to estimate the baseline risk. **Absolute risk with intervention cannot be estimated in the absence of absolute risk with the comparator. ***Risk difference cannot be estimated in the absence of absolute risks with intervention and the comparator. CI: Confidence interval; RR: Risk ratio. | |||||||
GRADE Working Group grades of evidence High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. |
a Direct evidence downgraded ‐2 due to severe imprecision (wide 95% CIs and number of events less than 30).